Incyte is trading 27.09% down at $92.54 after falling sharply from its September 22 regular-session close of $126.93; no clear company-specific catalyst has been identified.

  • September 22 coverage identified no clear company-specific catalyst. Incyte announced upcoming EADV portfolio data, while RBC reaffirmed Sector Perform with a $109 target.
  • The decline substantially outpaced the broader market. The reason remains uncertain, warranting a re-check for delayed news or a late filing.